(1)
EVALUATION OF THE USE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW. REMUNOM 2024, 12 (3), 1-13. https://doi.org/10.61164/rmnm.v12i3.3138.